(Q37038995)

17 August 2017

1 reference

title

An expert opinion on methylphenidate treatment for attention deficit hyperactivity disorder in pediatric patients with epilepsy (English)

1 reference

attention deficit hyperactivity disorder

17 August 2017

main subject

0 references

1 reference

5

Alcy Torres

1 reference

17 August 2017

author name string

Lourival Baptista-Neto

1

1 reference

17 August 2017

Alice Dodds

2

1 reference

17 August 2017

Sneha Rao

3

1 reference

17 August 2017

Jane Whitney

4

1 reference

17 August 2017

Joseph Gonzalez-Heydrich

6

1 reference

17 August 2017

language of work or name

English

0 references

publication date

1 January 2008

1 reference

Expert Opinion on Investigational Drugs

17 August 2017

published in

1 reference

17 August 2017

volume

17

1 reference

17 August 2017

issue

1

1 reference

17 August 2017

page(s)

77-84

1 reference

Differential diagnosis and treatment of psychiatric disorders in children and adolescents with epilepsy

17 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1517%2F13543784.17.1.77

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.17.1.77

Diagnosis and treatment of attention-deficit/hyperactivity disorder in children and adolescents. Council on Scientific Affairs, American Medical Association

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.17.1.77

Stimulant therapy and seizure risk in children with ADHD.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.17.1.77

Methylphenidate treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.17.1.77

Enantioselective behavioral effects of threo-methylphenidate in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.17.1.77

Enantioselective pharmacokinetics and pharmacodynamics of dl-threo-methylphenidate in children with attention deficit hyperactivity disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.17.1.77

Brain kinetics of methylphenidate (Ritalin) enantiomers after oral administration

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.17.1.77

Neuropsychopharmacological mechanisms of stimulant drug action in attention-deficit hyperactivity disorder: a review and integration

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.17.1.77

Imaging the effects of methylphenidate on brain dopamine: new model on its therapeutic actions for attention-deficit/hyperactivity disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.17.1.77

Is methylphenidate like cocaine? Studies on their pharmacokinetics and distribution in the human brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.17.1.77

The pharmacology of seizures induced by sensitization with low intensity brain stimulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.17.1.77

Medication-induced seizures

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.17.1.77

Seizures Associated With Venlafaxine, Methylphenidate, and Zolpidem

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.17.1.77

Components of attention in children with complex partial seizures with and without ADHD.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.17.1.77

An Evaluation of the Effects of Methylphenidate on Outcomes in Adult Epilepsy Patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.17.1.77

Effectiveness and safety of methylphenidate in adult attention deficit hyperactivity disorder in patients with epilepsy: an open treatment trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.17.1.77

Epilepsy and attention deficit hyperactivity disorder: is methylphenidate safe and effective?

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.17.1.77

Use of Methylphenidate for Attention-Deficit Hyperactivity Disorder in Patients With Epilepsy or Electroencephalographic Abnormalities

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.17.1.77

Methylphenidate therapy improves cognition, mood, and function of brain tumor patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.17.1.77

Methylphenidate Interaction With Both Anticonvulsants and Ethyl Biscoumacetate

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.17.1.77

Drug interactions: effect of methylphenidate on the disposition of diphenylhydantoin in man.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.17.1.77

Pharmacokinetic and pharmacodynamic drug interactions in the treatment of attention-deficit hyperactivity disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.17.1.77

Practice Parameter for the Assessment and Treatment of Children and Adolescents With Attention-Deficit/Hyperactivity Disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.17.1.77

21 January 2018

Identifiers

DOI

10.1517/13543784.17.1.77

1 reference

17 August 2017

1 reference